Jorge Cortes, MD, is the Director of the Georgia Cancer Center at Augusta University, Augusta, GA. Prof. Cortes previously served in the Department of Leukemia at the MD Anderson Cancer Center (MDACC) in Houston, TX, where he had roles including Deputy Department Chair and Professor of Medicine. Prof. Cortes received his medical degree in 1986 from the Universidad Nacional Autónoma de Mexico in Mexico City, and completed his fellowship in Houston.
Prof. Cortes has received various awards for his contributions in the leukemia field including the Annual Celgene Young Investigator Achievement Award for Clinical Research in Hematology in 2005, the Dr John J. Kenny Award from The Leukemia & Lymphoma Society in 2006, and the Otis W. and Pearl L. Walters Faculty Achievement Award in Clinical Research from MDACC in 2007. He has authored nearly 1,000 manuscripts in peer-reviewed journals and is the principal investigator or co-principal investigator of many research studies.
Speaking on leukemia
Prof. Cortes’ clinical interests include chronic and acute myeloid leukemia, particularly myeloproliferative neoplasms and myelodysplastic syndromes. His research focuses on new drug development, specifically, the development of tyrosine kinase inhibitors (TKI) such as bosutinib and ponatinib, as well as omacetaxine for chronic myeloid leukemia resistant to TKIs and glasdegib for older patients with acute myeloid leukemia.